IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis

BACKGROUND: The possibility to better predict the severity of the disease in a patient newly diagnosed with multiple sclerosis would allow the treatment strategy to be personalized and lead to better clinical outcomes. Prognostic biomarkers are highly needed. OBJECTIVE: To assess the prognostic valu...

Descripción completa

Detalles Bibliográficos
Autores principales: Petržalka, Marko, Meluzínová, Eva, Libertínová, Jana, Mojžišová, Hana, Hanzalová, Jitka, Ročková, Petra, Elišák, Martin, Kmetonyová, Silvia, Šanda, Jan, Sobek, Ondřej, Marusič, Petr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236235/
https://www.ncbi.nlm.nih.gov/pubmed/35759479
http://dx.doi.org/10.1371/journal.pone.0270607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236235/
https://www.ncbi.nlm.nih.gov/pubmed/35759479
http://dx.doi.org/10.1371/journal.pone.0270607

Ejemplares similares